Literature DB >> 17322499

Lower plasma adiponectin is a marker of increased intima-media thickness associated with type 2 diabetes mellitus and with male gender.

Robin P F Dullaart1, Rindert de Vries, Arie van Tol, Wim J Sluiter.   

Abstract

OBJECTIVE: We tested the extent to which altered plasma adipokine levels may contribute to the increased carotid artery intima-media thickness (IMT) associated with type 2 diabetes mellitus and with male gender, independently of conventional cardiovascular risk factors, insulin resistance, and plasma C-reactive protein (CRP).
DESIGN: IMT (mean of three segments of both carotid arteries by ultrasonography), insulin resistance (homeostasis model assessment; HOMA(ir)), plasma CRP, lipids, adiponectin, leptin, resistin, and tumor necrosis factor-alpha (TNF-alpha) were measured in 84 type 2 diabetic patients and 85 control subjects.
RESULTS: In diabetic patients, IMT (P<0.001), mean arterial pressure (P<0.001), HOMA(ir) (P<0.001), plasma CRP (P=0.003), triglycerides (P=0.037), leptin (P=0.023), resistin (P=0.003), and TNF-alpha (P=0.003) levels were higher, whereas high-density lipoproteins (HDL) cholesterol (P<0.001) and adiponectin (P<0.001) levels were lower compared with control subjects. Plasma adiponectin (P<0.001) and leptin (P<0.001) were substantially lower in men than in women. IMT was positively and independently associated with age (P<0.001), diabetes (P=0.049), and male gender (P=0.002) in a multivariate regression model, not including other variables. Further analyses showed that IMT was positively related to age (P<0.001) and plasma triglycerides (P=0.038) and negatively to adiponectin (P<0.001), without independent effects of diabetes, gender, and HOMA(ir).
CONCLUSIONS: Increased IMT in type 2 diabetes may in part be explained by lower plasma adiponectin and higher triglycerides, but not by leptin, resistin, and TNF-alpha. The gender effect on IMT is related to lower plasma adiponectin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17322499     DOI: 10.1530/EJE-06-0681

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  10 in total

Review 1.  Diabetic foot syndrome: Immune-inflammatory features as possible cardiovascular markers in diabetes.

Authors:  Antonino Tuttolomondo; Carlo Maida; Antonio Pinto
Journal:  World J Orthop       Date:  2015-01-18

2.  Hyperleptinemia: implications on the inflammatory state and vascular protection in obese adolescents submitted to an interdisciplinary therapy.

Authors:  Priscila L Sanches; Marco T de Mello; Natália Elias; Francisco A H Fonseca; Raquel M S Campos; June Carnier; Aline de Piano; Deborah C L Masquio; Patrícia L Silva; Lila M Oyama; Flavia C Corgosinho; Cláudia M O Nascimento; Lian Tock; Carolina Ackel D'Elia; Sergio Tufik; Ana R Dâmaso
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

3.  Association of Plasma Adiponectin and Oxidized Low-Density Lipoprotein with Carotid Intima-Media Thickness in Diabetic Nephropathy.

Authors:  Anna Tavridou; Anastasia Georgoulidou; Athanasios Roumeliotis; Stefanos Roumeliotis; Efstathia Giannakopoulou; Nikolaos Papanas; Ploumis Passadakis; Vangelis G Manolopoulos; Vassilis Vargemezis
Journal:  J Diabetes Res       Date:  2015-05-12       Impact factor: 4.011

4.  Subcutaneous adipose tissue plays a beneficial effect on subclinical atherosclerosis in young survivors of acute lymphocytic leukemia.

Authors:  Adriana Aparecida Siviero-Miachon; Angela Maria Spinola-Castro; Maria Lucia de Martino Lee; Carlos Manoel de Castro Monteiro; Antonio Carlos de Camargo Carvalho; Antonio Ramos Calixto; Bruno Geloneze; Gil Guerra-Junior
Journal:  Vasc Health Risk Manag       Date:  2015-08-18

Review 5.  Diabetic foot syndrome as a possible cardiovascular marker in diabetic patients.

Authors:  Antonino Tuttolomondo; Carlo Maida; Antonio Pinto
Journal:  J Diabetes Res       Date:  2015-03-26       Impact factor: 4.011

6.  Increased leptin/adiponectin ratio relates to low-normal thyroid function in metabolic syndrome.

Authors:  Lynnda J N van Tienhoven-Wind; Robin P F Dullaart
Journal:  Lipids Health Dis       Date:  2017-01-11       Impact factor: 3.876

7.  Expression of apolipoprotein M and its association with adiponectin in an obese mouse model.

Authors:  Liu Yang; Tie Li; Shuiping Zhao; Saidan Zhang
Journal:  Exp Ther Med       Date:  2019-07-09       Impact factor: 2.447

8.  Prospective randomized study for optimal insulin therapy in type 2 diabetic patients with secondary failure.

Authors:  Yumi Miyashita; Rimei Nishimura; Masami Nemoto; Toru Matsudaira; Hideaki Kurata; Tamotsu Yokota; Kuninobu Yokota; Katsuyoshi Tojo; Kazunori Utsunomiya; Naoko Tajima
Journal:  Cardiovasc Diabetol       Date:  2008-05-29       Impact factor: 9.951

Review 9.  Adiponectin gene polymorphisms and susceptibility to atherosclerosis: A meta-analysis.

Authors:  Marjan Mansourian; Shaghayegh Haghjooy Javanmard
Journal:  J Res Med Sci       Date:  2013-07       Impact factor: 1.852

10.  The anti-inflammatory function of HDL is impaired in type 2 diabetes: role of hyperglycemia, paraoxonase-1 and low grade inflammation.

Authors:  Sanam Ebtehaj; Eke G Gruppen; Mojtaba Parvizi; Uwe J F Tietge; Robin P F Dullaart
Journal:  Cardiovasc Diabetol       Date:  2017-10-12       Impact factor: 9.951

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.